Navigation Links
Increased cancer risk following the use of radioactive Radium-224 in the therapy
Date:6/23/2008

Ankylosing Spondylitis (Bechterew's Disease) is a painful chronic inflammatory rheumatic disease, associated with stiffening of the vertrebral column. Between 100,000 and 150,000 cases have already been diagnosed in Germany, but milder forms of the disease may remain undiagnosed.

The research team, led by Dr. Roland R. Wick, with Dr. Elke A. Nekolla, Prof. Dr. Albrecht M. Kellerer and the late Prof. Dr. Wolfgang Gssner have conducted a long-term follow-up study of 1,471 ankylosing spondylitis patients, whose disease symptoms were treated with repeated intravenous injections of 224Radium. A control cohort of 1,324 ankylosing spondylitis patients treated without the use of radioactive compounds and/or X-rays were also studied.

In the current publication an elevated rate of leukaemias was seen, a malignant disease of the haematopoietic system: In all, 19 observed cases of leukaemia were documented compared with 6.8 cases that would be expected in an age- and gender-matched cohort of a normal population. In particular, the incidence of acute myeloid leukaemia was significantly increased with 7.0 cases compared with 1.8 cases expected in a "normal" population.

Furthermore, four additional cases of preleukaemic diseases of the bone marrow were present in the exposed group and no cases in the control group. The frequency of leukaemia was not increased significantly in the control group compared with the expected value for a normal population.

"It is rather unlikely that impurities present in the radium preparations used before 1950 are responsible for the elevated appearance of myeloproliferative diseases in the exposed group observed here," commented Dr. Roland R. Wick. "In addition, the increased incidence of leukaemia is in line with experimental observations involving the treatment of animals with similar alpha emitting radioisotopes."

The results of these studies by the Helmholtz Zentrum Mnchen have contributed decisively to 224Radium preparations being declared obsolete and have resulted in the revocation of the licensing of SpondylAT by the Federal Institute for Drugs and Medical Devices (BfArM) and the decision by the licence holders to discontinue development of the treatment. In earlier legal proceedings the Cologne Administrative Court, in its decision of October 26th, 2006, came to the conclusion that the "increase of myeloid leukaemia [] could be explained causally with the deposition of radium as a calcium-like element into the bone", because, due to its short half-life of only 3.66 days, the radiation released from 224Radium has its effect mainly at the bone surface in the proximity of the blood-forming bone marrow cells.

Although previous studies have shown that radium treatment has an analgesic effect the risks of 224Radium treatment exceed its benefit, particularly, since there are many other therapeutic options available. Accordingly, the Committee for Quality Assurance of the German Society for Rheumatology no longer include this therapy in its recommendations.


'/>"/>

Contact: Dr. Roland R. Wick
wick@helmholtz-muenchen.de
49-893-187-2518
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Related medicine news :

1. Sangui BioTech Files Three 2007 Quarterly Reports, Sales Increased, Losses Continue
2. New Survey Demonstrates Increased Awareness of the Dangers of Meth Use
3. Decreased total sleep time associated with increased REM sleep during subsequent naps
4. Glaucoma report points to increased costs
5. Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate
6. Report confirms increased risk of smoking, substance abuse in bipolar adolescents
7. Fatty liver linked to increased risk of diabetic kidney disease
8. Microsoft HealthVault Be Well Fund Increased to $4.5 Million
9. Unilens Vision Reports Increased Royalty Income
10. Increased screening may better predict those at higher risk for heart disease, researchers report
11. Cumulative radiation exposure shows increased cancer risk for emergency department patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... ... welcoming new patients with periodontal plastic surgery treatments, including crown lengthening ... Dr. Green provides these esthetic and functional procedures to help patients improve their ...
(Date:5/22/2017)... ... 2017 , ... “Homeostasis: The Journey of a Manic-Depressive” tells the story in ... Rodriguez takes readers on a rollercoaster ride that includes a midnight trek to the ... a dark place where Donald considers suicide. Readers learn how Donald finally achieves ...
(Date:5/22/2017)... ... May 22, 2017 , ... WeightZone Factor a popular ... Factor members to track their exercise patterns, monitor behavioral changes, employ biometric monitoring, ... their mobile phones. It also provides social networks for members with similar interests ...
(Date:5/21/2017)... ... 19, 2017 , ... HealthSmart, the largest independent benefits administrator ... as Chief Information Officer (CIO). He will be joining HealthSmart at the end ... performance. He defines strategic roadmaps by reimagining business processes—bridging the gap between information ...
(Date:5/21/2017)... ... , ... Pot. Reefer. Grass. Mary Jane. No matter what people call it, ... never before. More than a map, new social marketplace Weedable goes beyond ... and for the first time – each other. A social marketplace like no other, ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 2017  The Corporate Whistleblower Center says, "We ... therapy clinics to call us anytime at 866-714-6466 if ... involved in a substantial scheme to overbill Medicare. ... an employee of a medical equipment company if ... provide medical practice groups with extra generous incentives to ...
(Date:5/10/2017)... 2017 CSSi, the global leader in patient ... industry, is proud to announce the launch of its ... features both enriched content and a customized layout that ... company,s already well-established position as the top global patient ... many months of hard work, we are delighted to ...
(Date:5/9/2017)... -- Demonstrating its commitment to representing research- based biopharmaceutical ... Research and Manufacturers of America (PhRMA) today approved ... have to meet new research and development (R&D) ... PhRMA. "By putting in place new ... message that being a member of PhRMA means ...
Breaking Medicine Technology: